These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38527031)

  • 1. 'Integrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives.
    Kariyawasam DS; Scarfe J; Meagher C; Farrar MA; Bhattacharya K; Carter SM; Newson AJ; Otlowski M; Watson J; Millis N; Norris S
    PLoS One; 2024; 19(3):e0299336. PubMed ID: 38527031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol.
    Lunke S; Bouffler SE; Downie L; Caruana J; Amor DJ; Archibald A; Bombard Y; Christodoulou J; Clausen M; De Fazio P; Greaves RF; Hollizeck S; Kanga-Parabia A; Lang N; Lynch F; Peters R; Sadedin S; Tutty E; Eggers S; Lee C; Wall M; Yeung A; Gaff C; Gyngell C; Vears DF; Best S; Goranitis I; Stark Z
    BMJ Open; 2024 Apr; 14(4):e081426. PubMed ID: 38569677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation.
    Rivero-Arias O; Png ME; White A; Yang M; Taylor-Phillips S; Hinton L; Boardman F; McNiven A; Fisher J; Thilaganathan B; Oddie S; Slowther AM; Ratushnyak S; Roberts N; Shilton Osborne J; Petrou S
    Health Technol Assess; 2024 Jun; 28(25):1-180. PubMed ID: 38938110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genomic newborn screening. Perspective from the Ethics Commission of the Spanish Society for Human Genetics. Part II: Ethical, legal and social issues (ELSIs) of the introduction of next generation sequencing technologies in a public health newborn screening program.].
    Pàmpols Ros T; Pérez Aytés A; García Sagredo JM; Díaz de Bustamante A; Blanco Guillermo I
    Rev Esp Salud Publica; 2022 Mar; 96():. PubMed ID: 35283479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian healthcare professionals' perspectives on the ethical and practical issues associated with genomic newborn screening.
    Cao M; Notini L; Ayres S; Vears DF
    J Genet Couns; 2023 Apr; 32(2):376-386. PubMed ID: 36245433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol.
    Nicholls SG; Tessier L; Etchegary H; Brehaut JC; Potter BK; Hayeems RZ; Chakraborty P; Marcadier J; Milburn J; Pullman D; Turner L; Wilson BJ
    BMJ Open; 2014 Nov; 4(11):e006782. PubMed ID: 25421341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understandings of genomic research in developing countries: a qualitative study of the views of MalariaGEN participants in Mali.
    Traore K; Bull S; Niare A; Konate S; Thera MA; Kwiatkowski D; Parker M; Doumbo OK
    BMC Med Ethics; 2015 Jun; 16():42. PubMed ID: 26077875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?
    White S; Mossfield T; Fleming J; Barlow-Stewart K; Ghedia S; Dickson R; Richards F; Bombard Y; Wiley V
    Eur J Hum Genet; 2023 Jun; 31(6):703-711. PubMed ID: 36935418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The BabySeq project: implementing genomic sequencing in newborns.
    Holm IA; Agrawal PB; Ceyhan-Birsoy O; Christensen KD; Fayer S; Frankel LA; Genetti CA; Krier JB; LaMay RC; Levy HL; McGuire AL; Parad RB; Park PJ; Pereira S; Rehm HL; Schwartz TS; Waisbren SE; Yu TW; ; Green RC; Beggs AH
    BMC Pediatr; 2018 Jul; 18(1):225. PubMed ID: 29986673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Racism in Newborn Drug Testing: Perspectives of Health Care and Child Protective Services Professionals.
    Shetty C; Oshman L; Costa A; Waidley V; Madlambayan E; Joassaint M; McCabe K; Townsel C; Wu JP; Frank CJ; Chandanabhumma PP
    Ann Fam Med; 2024; 22(4):271-278. PubMed ID: 39038971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed-methods evaluation of the NHS Genomic Medicine Service for paediatric rare diseases: study protocol.
    Lewis C; Buchanan J; Clarke A; Clement E; Friedrich B; Hastings-Ward J; Hill M; Horn R; Lucassen AM; Patch C; Pickard A; Roberts L; Sanderson SC; Wynn SL; Vindrola-Padros C; Lakhanpaul M
    NIHR Open Res; 2021; 1():23. PubMed ID: 35098132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol.
    Milko LV; Rini C; Lewis MA; Butterfield RM; Lin FC; Paquin RS; Powell BC; Roche MI; Souris KJ; Bailey DB; Berg JS; Powell CM
    Trials; 2018 Jun; 19(1):344. PubMed ID: 29950170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferences of parents from diverse backgrounds on genomic screening of apparently healthy newborns.
    Gold NB; Omorodion JO; Del Rosario MC; Rivera-Cruz G; Hsu CY; Ziniel SI; Holm IA
    J Genet Couns; 2024 Oct; ():. PubMed ID: 39465664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of rapid genomic sequencing in safety-net neonatal intensive care units: protocol for the VIrtual GenOme CenteR (VIGOR) proof-of-concept study.
    D'Gama AM; Hills S; Douglas J; Young V; Genetti CA; Wojcik MH; Feldman HA; Yu TW; G Parker M; Agrawal PB;
    BMJ Open; 2024 Feb; 14(2):e080529. PubMed ID: 38320840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic newborn screening: public health policy considerations and recommendations.
    Friedman JM; Cornel MC; Goldenberg AJ; Lister KJ; Sénécal K; Vears DF;
    BMC Med Genomics; 2017 Feb; 10(1):9. PubMed ID: 28222731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parents' Perspectives on Secondary Genetic Ancestry Findings in Pediatric Genomic Medicine.
    Richards JL; Knight SJ
    Clin Ther; 2023 Aug; 45(8):719-728. PubMed ID: 37573223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genomic newborn screening. Perspective from the Ethics commission of the Spanish Society for Human Genetics. Part I. Next generation sequencing technologies applied to newborn screening. Challenges and opportunities.].
    Pàmpols Ros T; Pérez Aytés A; García Sagredo JM; Díaz de Bustamante A; Blanco Guillermo I
    Rev Esp Salud Publica; 2022 Feb; 96():. PubMed ID: 35115483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.